LianBio

Canbridge Pharmaceuticals

This biopharmaceutical company develops and commercialises therapeutic drugs for patients with rare genetic diseases and orphan cancers in China and global markets.

Everest Medicines

This biopharmaceutical company develops and commercialises therapeutic products and vaccines to treat patients with unmet medical needs in Asia and global markets.

Nuvation Bio

This biopharmaceutical company develops and commercialises targeted oncology therapies for patients with cancers that have unmet medical needs.

Syndax

This biopharmaceutical company develops and commercialises targeted therapies for adult and paediatric patients with cancer and chronic graft-versus-host disease.

3SBio

This biopharmaceutical company develops and manufactures recombinant protein products for patients with oncology, nephrology, immunology, and autoimmune diseases.

Bridge BIO

This biopharmaceutical company develops and provides medicines for patients with genetic diseases and cancers with clear genetic drivers.

Coherus

This biopharmaceutical company develops and commercialises immuno-oncology therapies and biosimilar medicines for patients living with cancer and other serious inflammatory diseases.

Roivant

This biotech company develops and commercialises medicines and healthcare technologies for patients through its specialised subsidiary companies.